Asr Nederland N.v. · EURONEXT:ASRNL
Asr Nederland — Shareholder Meeting (May 2026)
51 slides from Asr Nederland's shareholder meeting presentation, May 20, 2026
Slide 1: Annual General Meeting 2026
Announcements Annual General Meeting 2026
Slide 2: Welcome and opening
1 Welcome and opening Joop Wijn Chair of the Supervisory Board
Slide 3: Announcements
Announcements
Slide 4: Supervisory Board & Management Board
Supervisory Board & Management Board Supervisory Board Joop Wijn Gerard van Olphen Sonja Barendregt GisellaofEikelenboom • Member the Supervisory Daniëlle Jansen • Member of Heijtmajer the Supervisory Lard Friese Bob Elfring Chair Vice-chair Board Board • Chair of the Remuneration • Member of the Au
Slide 5: Announcements: introduction of attendees, tape recording
Announcements Introduction other attendees Tape recording
Slide 6: Agenda
Agenda 1 Opening 2 2025 Annual Report 3 2025 Financial statements and dividend 4 Discharge 5 Extension of the authorisations of the Executive Board 6 Cancellation of shares 7 Composition of the Executive Board 8 Composition of the Supervisory Board 9 Questions before closing 10 Close
Slide 7: For vote
For vote 2d Remuneration report 2025 (advisory vote) 3a Proposal to adopt the financial statements for the 2025 financial year 3c Proposal to pay dividend 4a Proposal to grant discharge to the members of the Executive Board for the 2025 financial year 4b Proposal to grant discharge to the members of
Slide 8: Announcements: order of the meeting
Announcements Order of the meeting Webcast service (Dutch and English)
Slide 9: 2a Annual report 2025
2a Annual report 2025 Jos Baeten CEO and Chair of the Executive Board
Slide 10: Significant progress and proven success in executing our strategy
Significant progress and proven success in executing our strategy Balance sheet strengthening Unit-linked settlement Rational capital deployment Completion integration activities Delivering on all € Increased shareholder returns CMD promises Creating a leading insurer in the Netherlands
Slide 11: Strong results driven by disciplined strategy execution
Strong results driven by disciplined strategy execution Solvency II IFRS Growth Organic capital creation Operating result DC inflow € 1,315m € 1,637m € 3.0bn +10% +12% +9% Solvency II ratio Combined ratio Premiums received Non-life1 Non-life1 218% 92.2% € 4.1bn +20%-p +1.3%-p +3% 1 Excluding Health
Slide 12: Value creation for all stakeholders and compelling ESG credentials
Value creation for all stakeholders and compelling ESG credentials Non-financial targets1 Sustainable reputation Employee Gender diversity Carbon footprint Impact investments Customer satisfaction Public recognition engagement2 in management3 reduction % of investment portfolio Net Promotor Score (N
Slide 13: Aegon NL successfully integrated – all major milestones achieved
Aegon NL successfully integrated – all major milestones achieved Milestones of integration in 2025 Run-rate cost synergies ► Policy migration and integration of Mortgages and Individual life € 215m After final decommissioning in H1 2026 ► Implementation of the Partial Internal Model (PIM) for a.s.r.
Slide 14: Solid Non-life performance on both profitability and growth
Solid Non-life performance on both profitability and growth Combined ratio P&C and Disability (in %) Combined ratio P&C and Disability (in %) +3.0% +1.3%-p 3,968 4,085 90.9% 92.2% P&C 2,078 2,158 P&C 90.7% 90.4% Disability 1,890 1,927 Disability 91.2% 94.2% FY2024 FY 2024 1 1 FY 2025 FY 20241 FY 202
Slide 15: Strong commercial performance in Pensions continued
Strong commercial performance in Pensions continued DC (accumulation) Annuities (decumulation) Pension buy-outs DC accumulation inflow (in €m) Annuities inflow (in €m) Pension buy-outs inflow (in €m) € 8bn € 1.8bn € 8bn +8.8% +11.2% € 5.8bn € 1.2bn 2,768 3,011 581 646 2,810 € 2.9bn 69 FY 2024 FY 202
Slide 16: Fee-based businesses show strong growth with attractive margins
Fee-based businesses show strong growth with attractive margins Fee income € 812m +15.5% Operating result (in €m) +24.4% 186 Mortgage production 150 66 D&S € 9.0bn 50 -2.5% AM 120 100 Third party AuM Asset management and Real estate € 37.3bn FY 2024 FY 2025 +7.4%
Slide 17: Significant long-term value creation drives attractive capital returns
Significant long-term value creation drives attractive capital returns Total capital return since IPO € 4.9bn Market capitalisation since IPO Cumulative dividends: € 3.9bn Cumulative share buybacks: € 1.0bn Capital return (in €m) 980 Market Capitalisation (in €bn) 12.7 879 Share buyback DPS CAGR: 12
Slide 18: Dividend proposal 2025
Dividend proposal 2025 • 9% increase compared to 2024 € 3.41 DPS • Final dividend of € 2.14 per share • Interim dividend of € 1.27 per share (distributed in September 2025) • Total dividend over the year 2025 amounts € 700 million • Total capital return over the year 2025 amounts to € 930 million €
Slide 19: Key messages
Key messages ► Aegon NL successfully integrated; realisation of € 215m run-rate cost synergy target on track and 12%-p Solvency benefit from the application of PIM to a.s.r. Life ► Solid performance in all business segments supported by increased investment returns; OCC on track to achieve medium- t
Slide 20: Questions
Questions a. s.r.
Slide 21: 2b Report of the Supervisory Board / 2c Corporate Governance
2b Report of the Supervisory Board (for discussion) 2c Corporate Governance (for discussion)
Slide 22: 2d Remuneration report 2025 (for advisory vote)
2d Remuneration report 2025 (for advisory vote) Gisella Eikelenboom Chair of the Remuneration Committee
Slide 23: 2d Advisory vote to adopt the 2025 remuneration report
2d Advisory vote to adopt the 2025 remuneration report
Slide 24: Voting instructions
Voting instructions Electronic voting Number of shares entitled to vote
Slide 25: Test voting
Test voting Is tomorrow a Thursday? 1. For 2. Against 3. Abstained
Slide 26: 2d Advisory vote to adopt the 2025 remuneration report
2d Advisory vote to adopt the 2025 remuneration report
Slide 27: Financial statements & dividend 2025
3 Financial statements & dividend 2025 Sonja Barendregt Chair of the Audit & Risk Committee
Slide 28: Financial statements & dividend 2025
3 Financial statements & dividend 2025
Slide 29: Financial statements & dividend 2025
3 Financial statements & dividend 2025 Peti de Wit Partner at KPMG
Slide 30: Audit of the Annual Report 2025 | ASR NL (1/2)
Audit of the Annual Report 2025 | ASR NL (1/2) Our reports Materiality Financial statements • EUR 120 million. • Unqualified auditor’s report on the financial • 1.2% of total equity. o rts Ma statements (page 422). re p t • misstatements in excess of EUR 6 million ur are reported to the Supervisory
Slide 31: Audit of the Annual Report 2025 | ASR NL (2/2)
Audit of the Annual Report 2025 | ASR NL (2/2) Key audit matters (KAM) Estimates • Valuation of insurance contract • Overall assessment of estimates made by liabilities M Es management when preparing financial • Valuation of hard-to-value assets KA ti statements: fair and balanced. m at • Implementa
Slide 32: Questions
Questions a. s.r.
Slide 33: 3a Proposal to adopt the financial statements for 2025
3a Proposal to adopt the financial statements for the financial year 2025
Slide 34: 3b Explanation of the reserve and dividend policy
3b Explanation of the reserve and dividend policy (for discussion) 3c Proposal to pay dividend
Slide 35: 4a Proposal to grant discharge to the Executive Board
4a Proposal to grant discharge to the members of the Executive Board for the 2025 financial year
Slide 36: 4b Proposal to grant discharge to the Supervisory Board
4b Proposal to grant discharge to the members of the Supervisory Board for the 2025 financial year
Slide 37: Extension of the authorisation of the Executive Board
5 Extension of the authorisation of the Executive Board
Slide 38: 5a Proposal to extend authorisation to issue ordinary shares
5a Proposal to extend the authorisation of the Executive Board to issue ordinary shares and/or to grant rights to subscribe for ordinary shares
Slide 39: 5b Proposal to restrict or exclude pre-emption rights
5b Proposal to extend the authorisation of the Executive Board to restrict or exclude statutory pre-emption rights
Slide 40: 5c Proposal to authorise acquisition of own shares
5c Proposal to authorise the Executive Board to acquire the company’s own shares
Slide 41: 6a Proposal to cancel shares held by a.s.r.
6a Proposal to cancel shares held by a.s.r.
Slide 42: Composition of the Supervisory Board
8 Composition of the Supervisory Board
Slide 43: 8a Opportunity to make recommendations to the Supervisory Board
8a Opportunity for the General Meeting to make recommendations to the Supervisory Board
Slide 44: 8b Notice of nomination of Marco Keim and Sonja Barendregt
8b Notice of the nomination by the Supervisory Board for the appointment of Marco Keim and the reappointment of Sonja Barendregt as members of the Supervisory Board (for discussion)
Slide 45: 8c Proposal to appoint Marco Keim
8c Proposal to appoint Marco Keim as member of the Supervisory Board
Slide 46: 8d Proposal to reappoint Sonja Barendregt
8d Proposal to reappoint Sonja Barendregt as member of the Supervisory Board
Slide 47: Questions before closing
9 Questions before closing a. s.r.
Slide 48: Composition of the Executive Board
7 Composition of the Executive Board
Slide 49: 7a Intention to reappoint Ingrid de Swart and appoint her as CEO
7a The intention of the Supervisory Board to reappoint Ingrid de Swart as a member of the Executive Board and to appoint her as CEO and chair of the Executive Board and the Management Board (for discussion)
Slide 50: Announcements
Announcements
Slide 51: Annual General Meeting 2026
Announcements Annual General Meeting 2026